Skip to content
PICO Portalanswers from OpenAlex

Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice

PaperCitations, authors & open-access status

Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice is a paper indexed in PICO Portal from OpenAlex.

How many citations does Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice have?

PICO Portalcitation count

Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice has 463 citations in the OpenAlex counts PICO Portal stores.

When was Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice published?

PICO Portalyear

Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice has 2020 year in the PICO Portal index.

What is the open-access status of Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice?

PICO Portaloa status

Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice has bronze oa status in the PICO Portal index.

What is the DOI of Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice?

PICO Portaldoi

The DOI for Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice is on the source record.

What is the PMID of Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice?

PICO Portalpmid

The PMID for Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice is on the source record.

What is the OpenAlex record for Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice?

PICO Portalopenalex

The OpenAlex for Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial